George J. Bosl

20.6k total citations · 1 hit paper
330 papers, 14.2k citations indexed

About

George J. Bosl is a scholar working on Surgery, Neurology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, George J. Bosl has authored 330 papers receiving a total of 14.2k indexed citations (citations by other indexed papers that have themselves been cited), including 281 papers in Surgery, 102 papers in Neurology and 96 papers in Pulmonary and Respiratory Medicine. Recurrent topics in George J. Bosl's work include Testicular diseases and treatments (259 papers), Neuroblastoma Research and Treatments (99 papers) and Sarcoma Diagnosis and Treatment (80 papers). George J. Bosl is often cited by papers focused on Testicular diseases and treatments (259 papers), Neuroblastoma Research and Treatments (99 papers) and Sarcoma Diagnosis and Treatment (80 papers). George J. Bosl collaborates with scholars based in United States, Spain and Italy. George J. Bosl's co-authors include Robert J. Motzer, Dean F. Bajorin, Joel Sheinfeld, Victor E. Reuter, R. S. K. Chaganti, Jane Houldsworth, Nancy L. Geller, Jennifer Bacik, Madhu Mazumdar and Harry W. Herr and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

George J. Bosl

326 papers receiving 13.8k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Testicular Germ-Cell Cancer

1997 645 citations George J. Bosl, Robert J. Motzer New England Journal of Medicine profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
George J. Bosl	10.6k	4.1k	3.8k	3.5k	2.6k	330	14.2k
David M. Gershenson	5.9k 0.6×	4.2k 1.0×	2.5k 0.7×	483 0.1×	12.0k 4.6×	406	21.6k
Silvana Pilotti	2.7k 0.3×	5.1k 1.2×	5.3k 1.4×	1.3k 0.4×	375 0.1×	294	16.2k
Suzanne George	2.1k 0.2×	1.8k 0.4×	6.8k 1.8×	1.4k 0.4×	541 0.2×	257	11.7k
Manisha H. Shah	2.4k 0.2×	4.3k 1.0×	3.3k 0.9×	3.1k 0.9×	184 0.1×	203	18.0k
Antoîne Italiano	2.6k 0.2×	4.0k 1.0×	9.2k 2.4×	831 0.2×	377 0.1×	618	17.5k
Martee L. Hensley	1.6k 0.2×	1.8k 0.4×	4.7k 1.2×	244 0.1×	3.8k 1.4×	223	13.3k
Terry L. Smith	1.8k 0.2×	2.8k 0.7×	2.6k 0.7×	514 0.1×	446 0.2×	154	16.0k
Paul Elson	3.2k 0.3×	4.5k 1.1×	5.6k 1.5×	397 0.1×	354 0.1×	334	13.4k
Alberto S. Pappo	2.4k 0.2×	2.4k 0.6×	6.7k 1.8×	1.9k 0.6×	105 0.0×	308	11.6k
Margaret von Mehren	5.0k 0.5×	2.2k 0.5×	10.7k 2.8×	2.4k 0.7×	140 0.1×	282	16.3k

Countries citing papers authored by George J. Bosl

Since Specialization

Citations

This map shows the geographic impact of George J. Bosl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by George J. Bosl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites George J. Bosl more than expected).

Fields of papers citing papers by George J. Bosl

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by George J. Bosl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by George J. Bosl. The network helps show where George J. Bosl may publish in the future.

Co-authorship network of co-authors of George J. Bosl

This figure shows the co-authorship network connecting the top 25 collaborators of George J. Bosl. A scholar is included among the top collaborators of George J. Bosl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with George J. Bosl. George J. Bosl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Knežević, Andrea, Sujata Patil, Joel Sheinfeld, et al.. (2024). Paclitaxel, Ifosfamide, and Cisplatin as Initial Salvage Chemotherapy for Germ Cell Tumors: Long-Term Follow-Up and Outcomes for Favorable- and Unfavorable-Risk Disease. Journal of Clinical Oncology. 42(26). 3130–3139. 4 indexed citations

Pietzak, Eugene J., Melissa Assel, Maria F. Becerra, et al.. (2018). Histologic and Oncologic Outcomes Following Liver Mass Resection With Retroperitoneal Lymph Node Dissection in Patients With Nonseminomatous Germ Cell Tumor. Urology. 118. 114–118. 6 indexed citations

Meisel, Jane, Kaitlin M. Woo, Sujata Patil, et al.. (2015). Development of a risk stratification system to guide treatment for female germ cell tumors. Gynecologic Oncology. 138(3). 566–572. 28 indexed citations

Thodima, Venkata J., et al.. (2014). miR-18b and miR-518b Target FOXN1 During Epithelial Lineage Differentiation in Pluripotent Cells. Stem Cells and Development. 23(10). 1149–1156. 11 indexed citations

Cavallo, Francesca, Grazia Graziani, Cristina Antinozzi, et al.. (2012). Reduced Proficiency in Homologous Recombination Underlies the High Sensitivity of Embryonal Carcinoma Testicular Germ Cell Tumors to Cisplatin and Poly (ADP-Ribose) Polymerase Inhibition. PLoS ONE. 7(12). e51563–e51563. 78 indexed citations

Sarkaria, Inderpal S., Manjit S. Bains, Camelia S. Sima, et al.. (2011). Resection of Primary Mediastinal Non-Seminomatous Germ Cell Tumors: A 28-Year Experience at Memorial Sloan-Kettering Cancer Center. Journal of Thoracic Oncology. 6(7). 1236–1241. 30 indexed citations

Feldman, Darren R., Joel Sheinfeld, Dean F. Bajorin, et al.. (2010). TI-CE High-Dose Chemotherapy for Patients With Previously Treated Germ Cell Tumors: Results and Prognostic Factor Analysis. Journal of Clinical Oncology. 28(10). 1706–1713. 147 indexed citations

Korkola, James E., Jane Houldsworth, Rajendrakumar S.V. Chadalavada, et al.. (2006). Down-Regulation of Stem Cell Genes, Including Those in a 200-kb Gene Cluster at 12p13.31, Is Associated with In vivo Differentiation of Human Male Germ Cell Tumors. Cancer Research. 66(2). 820–827. 236 indexed citations

Alektiar, Kaled M., et al.. (2004). Long-term disease control and patterns of failure in early stage testicular seminoma treated with limited or extended-field radiotherapy portals. International Journal of Radiation Oncology*Biology*Physics. 60(1). S271–S272. 2 indexed citations

10.

Murty, Vundavalli V., Kate Montgomery, Shashi Bala, et al.. (1999). A 3-Mb High-Resolution BAC/PAC Contig of 12q22 Encompassing the 830-kb Consensus Minimal Deletion in Male Germ Cell Tumors. Genome Research. 9(7). 662–671. 17 indexed citations

11.

Xiao, Han, David Liu, Dean F. Bajorin, Michael Burt, & George J. Bosl. (1998). MEDICAL AND SURGICAL MANAGEMENT OF PULMONARY METASTASES FROM GERM CELL TUMORS. Chest Surgery Clinics of North America. 8(1). 131–144. 6 indexed citations

12.

Motzer, Robert J., Alison Amsterdam, Víctor G. Prieto, et al.. (1998). TERATOMA WITH MALIGNANT TRANSFORMATION: DIVERSE MALIGNANT HISTOLOGIES ARISING IN MEN WITH GERM CELL TUMORS. The Journal of Urology. 159(1). 133–138. 289 indexed citations

13.

Xiao, Han, Madhu Mazumdar, Dean F. Bajorin, et al.. (1997). Long-term follow-up of patients with good-risk germ cell tumors treated with etoposide and cisplatin.. Journal of Clinical Oncology. 15(7). 2553–2558. 43 indexed citations

14.

Motzer, Robert J., Madhu Mazumdar, Dean F. Bajorin, et al.. (1997). High-dose carboplatin, etoposide, and cyclophosphamide with autologous bone marrow transplantation in first-line therapy for patients with poor-risk germ cell tumors.. Journal of Clinical Oncology. 15(7). 2546–2552. 112 indexed citations

15.

Bosl, George J. & Robert J. Motzer. (1997). Testicular Germ-Cell Cancer. New England Journal of Medicine. 337(4). 242–254. 645 indexed citations breakdown →

16.

Motzer, Robert J., Joel Sheinfeld, Madhu Mazumdar, et al.. (1995). Etoposide and cisplatin adjuvant therapy for patients with pathologic stage II germ cell tumors.. Journal of Clinical Oncology. 13(11). 2700–2704. 49 indexed citations

17.

Motzer, Robert J., Eddie Reed, Deliang Tang, et al.. (1994). Platinum-DNA adducts assayed in leukocytes of patients with germ cell tumors measured by atomic absorbance spectrometry and enzyme-linked immunosorbent assay. Cancer. 73(11). 2843–2852. 32 indexed citations

18.

Chou, Ting‐Chao, Robert J. Motzer, Yanli Tong, & George J. Bosl. (1994). Computerized Quantitation of Synergism and Antagonism of Taxol, Topotecan, and Cisplatin Against Human Teratocarcinoma Cell Growth: a Rational Approach to Clinical Protocol Design. JNCI Journal of the National Cancer Institute. 86(20). 1517–1524. 465 indexed citations

19.

Motzer, Robert J. & George J. Bosl. (1992). High-Dose Chemotherapy for Resistant Germ Cell Tumors: Recent Advances and Future Directions. JNCI Journal of the National Cancer Institute. 84(22). 1703–1709. 55 indexed citations

20.

Nanus, David M. & George J. Bosl. (1989). Systemic chemotherapy in the management of bladder cancer. Cancer treatment and research. 46. 143–158. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact